T. Geiser (Bern, Switzerland), H. Fehrenbach (Marburg, Germany)
Interleukin-13 receptor alpha 2: a regulator of IL-13 and IL-4 signal transduction
A. L. Andrews, J. W. Holloway, S. T. Holgate, D. E. Davies (Southampton, United Kingdom)
|  |
Role of IκB kinases (IKKs) α and β in severe asthma and COPD
R. Gagliardo, F. Pompeo, A. M. Merendino, M. Gjomarkaj, I. Vachier, J. Bousquet, G. Bonsignore, P. Chanez (Palermo, Italy; , ; Montpellier, France)
| |
Human myeloid lung dendritic cells are strong inducers of T cell proliferation compared to plasmacytoid lung dendritic cells
I. K. Demedts, G. F. Joos, G. G. Brusselle (Ghent, Belgium)
|  |
CC chemokine receptor 3 inhibitor, antileukinate, suppressed ovalbumin induced goblet cell metaplasia and airway hyperresponsiveness in mice
M. Tanaka, S. Hayashi, Y. Fukuno (Saga, Japan)
| |
Effect of IL-13Rα2 Receptor levels on the biological activity of IL-13 variant R110Q
A. L. Andrews, F. Buccherri, K. Arima, K. Izuhara, S. T. Holgate, D. E. Davies, J. W. Holloway (Southampton, United Kingdom; Kyoto, Japan)
| |
Reduced bronchial epithelial Smad7 protein expression in COPD
A. Zandvoort, D. S. Postma, M. R. Jonker, J. A. Noordhoek, J. T. Vos, W. Timens (Groningen, Netherlands)
| |
Estrogen receptor 1 polymorphisms are associated with bronchial hyperresponsiveness and FEV1 decline, particularly in female asthmatics
A. Dijkstra, T. Howard, J. Vonk, E. J. Ampleford, L. Lange, E. R. Bleecker, D. A. Meyers, D. S. Postma (Groningen, Netherlands; Winston-Salem, United States Of America)
| |
ADAM33 SNPs are associated with airway hyperresponsiveness and airway inflammation in COPD
M. M. Gosman, H. M. Boezen, C. C. van Diemen, J. B. Snoeck-Stroband, T. S. Lapperre, P. S. Hiemstra, N. H. ten Hacken, J. Stolk, D. S. Postma (Groningen, Leiden, Netherlands)
| |